Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05300971 · ClinicalTrials.gov registry record · NA

Passive Heat Therapy for Lowering Systolic Blood Pressure and Improving Vascular Function in Mid-life and Older Adults

A NA study of Aging, sponsored by University of Colorado, Boulder.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05300971 is a NA study of Aging that is actively recruiting participants, run by University of Colorado, Boulder. The registered enrollment target is 150 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05300971, a NA study of Aging, is actively recruiting participants, sponsored by University of Colorado, Boulder.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study aims to determine the effects of \~12 weeks of repeated hot water immersion ("heat therapy") vs. thermoneutral water immersion on blood pressure and vascular function in late middle-life to older (≥40 years) adults. The study also aims to determine the effects of \~12 weeks of heat therapy on fluid cognitive and cerebrovascular function.

Conditions Studied

Interventions

  • OTHER Heat therapy
  • OTHER Thermoneutral water immersion

Study Locations (1)

Colorado

  • University of Colorado Boulder - Boulder

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-08-01
Est. Completion 2028-02-01
Phase NA

Sponsor

University of Colorado, Boulder

69 total trials

What the Registry Record Tells You About NCT05300971

The ClinicalTrials.gov registry entry for NCT05300971 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (93% lower). The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Heat therapy is the first listed.

NCT05300971 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT05300971 about?

NCT05300971 is a clinical study titled "Passive Heat Therapy for Lowering Systolic Blood Pressure and Improving Vascular Function in Mid-life and Older Adults". This study aims to determine the effects of \~12 weeks of repeated hot water immersion ("heat therapy") vs. thermoneutral water immersion on blood pressure and vascular function in late middle-life to older (≥40 years) adults. The study also aims to determine the effects of \~12 weeks of heat therap...

What is the current status of trial NCT05300971?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2022-08-01. Estimated completion is 2028-02-01.

What conditions does trial NCT05300971 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT05300971?

The interventions under investigation include: Heat therapy (OTHER), Thermoneutral water immersion (OTHER).

Who is sponsoring clinical trial NCT05300971?

This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05300971 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.